WoundRounds: Soft Tissue Reconstruction of Complex Wounds

For this month’s WOUNDS Global Rounds series, we provide education about the world’s first and most clinically evaluated synthetic dermal matrix. Drs. Marcus Wagstaff, Kyle Chepla, and Shaun Mendenhall will each discuss their recent publications where they apply a synthetic Biodegradable Temporizing Matrix as a treatment alternative for complex wounds requiring significant soft-tissue reconstruction. Topics will include data analysis from each of their large case series – overall product performance and cost to the patient, surgeon, and hospital.

Over the last 5 years there has been exponential growth of clinical investigations and evidence shown of NovoSorb BTM. A literature review of 172 publications, the vast majority independent of PolyNovo, was conducted to better understand the performance of NovoSorb BTM in the hands of numerous surgeons across the globe.

To assess performance, an analysis of all publications (released by 2022) was conducted with the following inclusion criteria: underwent peer-review, contained published data, did not overlap previously published data, included endpoints of BTM take, skin graft take, and/ or number of applications. 50 publications met the criteria (3 of 50 sponsored by PolyNovo) and all 241 NovoSorb BTM patients in the publications were included.